Stephen L. Rose, MD Print Friendly PageFaculty, University of Wisconsin School of Medicine and Public Health
Board certified in obstetrics and gynecology, Dr. Rose is a member of the Gynecologic Oncology staff, specializing in the surgical and chemotherapeutic treatment of gynecologic cancers. He is a 2007 Liz Tilberis Scholars award winner from the Ovarian Cancer Research Fund, Inc. for his laboratory research on the role of Notch pathway signaling in ovarian cancer. His research interests include quality of life issues for gynecologic cancer patients, gynecologic cancer survivorship, and basic and translational science research of gynecologic cancers.
UW Health Clinics
|Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.|
UW School of Medicine and Public Health
|Department of Obstetrics and Gynecology|
Professional Certifications and Education
Obstetrics & Gynecology
University of Iowa Hospitals and Clinics, Iowa City
St. Vincent Hospital and Health Services, Indianapolis
Indiana University, Indianapolis
Rose SL Spencer RJ Rausch MM .
The use of humor in patients with recurrent ovarian cancer: a phenomenological study. Int J Gynecol Cancer. 2013 May;23(4):775-9
[PubMed ID: 23552803]
Lin JE Seo S Kushner DM Rose SL .
The role of appendectomy for mucinous ovarian neoplasms. Am J Obstet Gynecol. 2013 Jan;208(1):46.e1-4
[PubMed ID: 23117124]
Uppal S Hernandez E Dutta M Dandolu V Rose S Hartenbach E .
Prolonged postoperative venous thrombo-embolism prophylaxis is cost-effective in advanced ovarian cancer patients. Gynecol Oncol. 2012 Dec;127(3):631-7
[PubMed ID: 22940486]
Baggott CD Einstein MH Miranpuri A Rose SL Kuo JS .
What is the optimal venous thromboembolism prophylaxis for gynecological oncology patients with CNS metastases? Gynecol Oncol. 2011 Nov;123(2):409-10
[PubMed ID: 21807402]
Drenzek JG Seiler NL Jaskula-Sztul R Rausch MM Rose SL .
Xanthohumol decreases Notch1 expression and cell growth by cell cycle arrest and induction of apoptosis in epithelial ovarian cancer cell lines. Gynecol Oncol. 2011 Aug;122(2):396-401
[PubMed ID: 21616523]
Rose SL .
Where once there was color. Obstet Gynecol. 2011 Jan;117(1):143-4
[PubMed ID: 21173656]
Rose SL Kunnimalaiyaan M Drenzek J Seiler N .
Notch 1 signaling is active in ovarian cancer. Gynecol Oncol. 2010 Apr;117(1):130-3
[PubMed ID: 20060575]
Bradford L Swartz K Rose S .
Primary angiosarcoma of the ovary complicated by hemoperitoneum: a case report and review of the literature. Arch Gynecol Obstet. 2010 Jan;281(1):145-50
[PubMed ID: 19396453]
Rose SL .
Notch signaling pathway in ovarian cancer. Int J Gynecol Cancer. 2009 May;19(4):564-6
[PubMed ID: 19509550]
DiFeo A Narla G Hirshfeld J Camacho-Vanegas O Narla J Rose SL Kalir T Yao S Levine A Birrer MJ Bonome T Friedman SL Buller RE Martignetti JA .
Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination. Clin Cancer Res. 2006 Jun 15;12(12):3730-9
[PubMed ID: 16778100]